News

The mid-stage trial results announced by the pharmaceutical giant showed that patients taking orforglipron lost an average of 16 pounds.
This month’s panic-driven selling across municipal bonds — fueled by the boom in ETFs — is proving a mixed blessing for ...
A double-digit selloff in UnitedHealth Group Inc. is dragging down the blue-chip Dow Jones Industrial Average, pushing it ...
US stock futures traded flat on the heels of a bruising day on Wall Street that underscored fears over the economic impact of ...
Nvidia CEO Jensen Huang's wealth is down by almost a fifth this year, while Michael Dell has taken a $26 billion hit amid a ...
U.S. stocks fell Wednesday after Nvidia warned new restrictions on exports to China will chisel billions of dollars off its ...
On April 15 and 16, 2025, a claim (archived) circulated online that China had halted or canceled all its orders of airplanes ...
Semiconductor stocks fell after the Trump administration blocked companies from selling certain chips to China without a ...
Crocs Inc. CEO Andrew Rees, in an internal company memo, warned employees of ongoing "volatility” related to supply-chain ...
Nasdaq 100 E-Mini futures (NQM25) are trending down -1.22% this morning as sentiment took a hit after the Trump ...
Beleaguered stock bulls are getting an encouraging sign from the people who know the companies best. Corporate insiders ...
Stock-market volatility has seen outsized swings up and down this month, as investors contend with uncertain negotiations ...